Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL
Game-changing treatments for leukemia
Can concepts from CLL be applied to other liquid and solid tumors?
The future of CLL treatment
Myeloma highlights from ASCO 2017